Fundraising FoxOrganOx
Oxford, GB · 8 known investors
Find your way into OrganOx
Sign up to find every way you can get introduced to OrganOx
- Your email: who you already know at OrganOx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the OrganOx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.
Founders & leadership
Investors · 8
How we know: Amadeus Capital Partners's portfolio page · Not right? Tell us
How we know: Business Growth Fund's portfolio page · Not right? Tell us
How we know: HealthQuest Capital's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: Lauxera Capital Partners's portfolio page · funding news · globenewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountgrowth roundJul 2023
Lauxera Capital Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
5 people who came through OrganOx went on to found or lead other companies.
Companies House · registry record
View on Companies House ↗- Registered name
- ORGANOX LIMITED
- Company number
- 06557113
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 7 Apr 2008
- Registered office
- 125 Wood Street, London, EC2V 7AW
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Accounts
- last made up to 31 Dec 2024 · next due 31 Dec 2026
- Confirmation statement
- last made up to 7 Apr 2026 · next due 21 Apr 2027
Current officers · 6
- Annabel Andrew — secretary, appointed 1 May 2025
- Jin Hagimoto — director, appointed 29 Oct 2025
- Takuya Hosokai — director, appointed 29 Oct 2025
- Naoya Iwata — director, appointed 1 Jun 2026
- Norimasa Kunimoto — director, appointed 29 Oct 2025
- Bhawna Menghnani — director, appointed 1 Apr 2026
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does OrganOx do?
- OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.
- Who founded OrganOx?
- OrganOx was founded by Prof. Peter Friend.
- Who are OrganOx's investors?
- OrganOx's investors include Amadeus Capital Partners, Business Growth Fund, HealthQuest Capital, Intuitive Ventures, Lauxera Capital Partners, Longwall Venture Partners LLP, Oxford University Innovation, Perivoli Innovations.
- Where is OrganOx headquartered?
- OrganOx is headquartered in Oxford, GB.